Kestra Medical Technologies (KMTS) reported its Q2 2026 financial results on September 14, 2026, after market close. The company announced a revenue of 31 million USD and an EPS of -0.75 USD, which missed the analyst estimate of -0.62 USD by 21.7%. Following the release, the stock price rose by 4.66%.
Generated automatically from our data — as of September 26, 2026
Key figures at a glance
Estimate (EPS): -0.62 USD
Reported (EPS): -0.75 USD
Price reaction: +4.7%
Frequently asked questions
Did Kestra Medical Technologies beat or miss earnings-per-share expectations?
Kestra Medical Technologies missed the analyst estimate of -0.62 USD earnings per share (Q2 2026) by 21.7%, reporting only -0.75 USD.
How did Kestra Medical Technologies stock react to the earnings report?
Kestra Medical Technologies stock rose 4.7% on the trading day following the release.
What was Kestra Medical Technologies's revenue in Q2 2026?
Kestra Medical Technologies reported revenue of 31M USD in Q2 2026.